• Friedrich Schering. As a result of nationalization, it became an independent company. In 1971, the Schering Corporation merged with Plough, Inc. (founded...
    24 KB (1,974 words) - 12:48, 8 July 2024
  • mergers and acquisitions, including the mergers between Merck and Schering-Plough, the acquisition of Bausch + Lomb by Valeant Pharmaceuticals, and the...
    11 KB (972 words) - 18:51, 18 July 2024
  • Thumbnail for Dr. Scholl's
    Dr. Scholl's (category Drugs developed by Schering-Plough)
    Schering-Plough bought the Dr. Scholl's brand in 1979. In 2009, Merck & Co. purchased the Dr. Scholl's brand as part of its acquisition of Schering-Plough...
    9 KB (633 words) - 21:44, 15 June 2024
  • Thumbnail for Schering AG
    American pharmaceutical company Schering-Plough, formerly the Schering Corporation, was originally the US subsidiary of Schering AG, and merged with Merck &...
    12 KB (1,284 words) - 20:30, 16 November 2023
  • Thumbnail for Loratadine
    Loratadine (category Drugs developed by Schering-Plough)
    quetiapine. Schering-Plough developed loratadine as part of a quest for a potential blockbuster drug: a nonsedating antihistamine. By the time Schering submitted...
    30 KB (2,563 words) - 05:06, 27 May 2024
  • Jean-Pierre Garnier (category Schering-Plough)
    Pasteur University in Strasbourg. He joined the Belgian subsidiary of Schering-Plough in 1978. From 1989 to 1990 he was the manager of the US pharmaceuticals...
    3 KB (150 words) - 12:54, 20 May 2024
  • Thumbnail for Mirtazapine
    Mirtazapine (category Drugs developed by Schering-Plough)
    Mirtazapine, sold under the brand name Remeron among others, is an atypical tetracyclic antidepressant, and as such is used primarily to treat depression...
    87 KB (7,810 words) - 06:35, 18 August 2024
  • Thumbnail for Montelukast
    August 2017. "Schering-Plough/Merck Pharmaceuticals Receives Not-Approvable Letter from FDA for Loratadine/Montelukast". Schering-Plough (Press release)...
    27 KB (2,283 words) - 22:41, 8 June 2024
  • Thumbnail for Coppertone (sunscreen)
    Coppertone (sunscreen) (category Drugs developed by Schering-Plough)
    1957 Plough acquires Coppertone 1971 Schering Corporation merges with Plough to form Schering-Plough 2009 Merck & Co. acquires Schering-Plough 2014 Bayer...
    7 KB (605 words) - 19:07, 27 May 2024
  • Thumbnail for Desloratadine
    Desloratadine (category Drugs developed by Schering-Plough)
    in 2001. It was brought to the market in the US by Schering Corporation, later named Schering-Plough. Desloratadine is used to treat allergic rhinitis...
    14 KB (1,039 words) - 04:17, 1 June 2024
  • 28 September 2007. Retrieved 25 August 2012. "$500 million fine for Schering-Plough". The Philadelphia Inquirer. 18 May 2002. Retrieved 25 August 2012...
    14 KB (799 words) - 00:21, 21 August 2024
  • repatriation tax avoidance strategies, including Merck & Co.'s acquisition of Schering-Plough and Johnson & Johnson's acquisition of Synthes. The use of repatriation...
    17 KB (2,020 words) - 17:13, 9 February 2023
  • 600. The company had strategic relationships with GlaxoSmithKline, Schering-Plough, and Sanofi-Aventis. ViroPharma acquired Lev Pharmaceuticals in a merger...
    9 KB (760 words) - 14:28, 10 July 2024
  • Organon & Co. (category Schering-Plough)
    November 2007, Schering-Plough acquired Organon BioSciences and veterinary pharmaceutical company Intervet from Akzo Nobel. Schering-Plough transferred Organon...
    12 KB (1,002 words) - 10:52, 16 August 2024
  • Thumbnail for Triamcinolone
    Triamcinolone (category Drugs developed by Schering-Plough)
    Triamcinolone is a glucocorticoid used to treat certain skin diseases, allergies, and rheumatic disorders among others. It is also used to prevent worsening...
    19 KB (1,498 words) - 19:56, 10 August 2024
  • Thumbnail for Merck & Co.
    Merck & Co. (category Schering-Plough)
    Inc (Acq 1993, Spun off 2003) ScheringPlough Schering-Plough (Merged 1971) Schering Corporation (Founded 1851) Plough, Inc (Founded 1908) Organon International...
    96 KB (9,392 words) - 08:18, 3 August 2024
  • Thumbnail for Garenoxacin
    Schering-Plough holds worldwide rights for garenoxacin, except for Japan, South Korea, and China.[citation needed] On February 13, 2006, Schering-Plough...
    5 KB (317 words) - 19:09, 10 August 2023
  • Thumbnail for Buprenorphine
    Buprenorphine (category Drugs developed by Schering-Plough)
    Buprenorphine, sold under the brand name Subutex among others, is an opioid used to treat opioid use disorder, acute pain, and chronic pain. It can be...
    81 KB (7,327 words) - 15:27, 16 August 2024
  • Thumbnail for Mometasone
    Mometasone (category Drugs developed by Schering-Plough)
    Mometasone, also known as mometasone y 3 s, is a steroid (specifically, a glucocorticoid) medication used to treat certain skin conditions, hay fever,...
    31 KB (2,608 words) - 03:56, 22 August 2024
  • in the 1960s. In 1967, the company was sold by Williams to Plough Inc. (now Schering-Plough) in Memphis, Tennessee. The cosmetic production facility was...
    10 KB (831 words) - 15:12, 17 June 2024
  • Thumbnail for Ezetimibe
    Ezetimibe (category Drugs developed by Schering-Plough)
    Ezetimibe is a medication used to treat high blood cholesterol and certain other lipid abnormalities. Generally it is used together with dietary changes...
    20 KB (1,819 words) - 11:14, 1 July 2024
  • Thumbnail for Coricidin
    Coricidin (category Drugs developed by Schering-Plough)
    suppressant) and chlorpheniramine maleate (an antihistamine). Introduced by Schering-Plough in 1949 as one of the first antihistamines, it is now owned by Bayer...
    8 KB (632 words) - 18:56, 21 December 2023
  • Thumbnail for Interferon type I
    IFNα2a (Roferon-A, Roche), IFNα2b (Intron-A, Schering-Plough) and pegylated IFNα2b (Sylatron, Schering Corporation) for treatment of hairy cell leukemia...
    24 KB (2,932 words) - 03:26, 14 June 2024
  • Thumbnail for Sugammadex
    Newhouse Research Site in Scotland. Organon was acquired by Schering-Plough in 2007; Schering-Plough merged with Merck in 2009. Sugammadex is now owned and...
    20 KB (1,642 words) - 02:15, 16 July 2024
  • Thumbnail for Vardenafil
    Vardenafil (category Drugs developed by Schering-Plough)
    Vardenafil was co-marketed by Bayer Pharmaceuticals, GlaxoSmithKline, and Schering-Plough under the brand name Levitra. As of 2005, the co-promotion rights of...
    10 KB (814 words) - 04:38, 1 August 2024
  • Thumbnail for Famciclovir
    Famciclovir (category Drugs developed by Schering-Plough)
    Famciclovir is a guanosine analogue antiviral drug used for the treatment of various herpesvirus infections, most commonly for herpes zoster (shingles)...
    9 KB (734 words) - 04:11, 2 April 2024
  • Thumbnail for Risperidone
    Risperidone (category Drugs developed by Schering-Plough)
    Risperidone, sold under the brand name Risperdal among others, is an atypical antipsychotic used to treat schizophrenia and bipolar disorder, as well as...
    55 KB (5,050 words) - 01:14, 26 August 2024
  • Thumbnail for Human chorionic gonadotropin
    Human chorionic gonadotropin (category Drugs developed by Schering-Plough)
    Human chorionic gonadotropin (hCG) is a hormone for the maternal recognition of pregnancy produced by trophoblast cells that are surrounding a growing...
    49 KB (5,376 words) - 23:12, 24 August 2024
  • Fred Hassan (category Schering-Plough)
    as chairman and CEO of Schering Plough (SGP), then a struggling pharmaceutical company. As chairman and CEO of Schering Plough (SGP), Hassan oversaw the...
    29 KB (2,698 words) - 00:14, 21 August 2024
  • Schering-Plough, an American pharmaceutical company Hoechst Schering AgrEvo GmbH, a German company owned by Hoechst AG and Schering AG Ernst Schering...
    505 bytes (99 words) - 12:43, 11 July 2017